NCT05856630 2023-05-12
Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mg
Luye Pharma Group Ltd.
Phase 1 Unknown
Luye Pharma Group Ltd.
Shanghai Junshi Bioscience Co., Ltd.
Tianjin Medical University Cancer Institute and Hospital